DICETEL 100 MG
PINAVERIUM BROMIDE : 100 MG · DIN 02230684 · BGP PHARMA ULC
Health Canada status: MARKETED
What is DICETEL?
DICETEL 100 MG contains PINAVERIUM BROMIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02230684, held by BGP PHARMA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 09-Mar-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DICETEL used for?
Treatment and relief of symptoms associated with irritable bowel syndrome (IBS); treatment of symptoms related to functional disorders of the biliary tract.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02230684 |
|---|---|
| Brand name | DICETEL |
| Generic / active ingredient | PINAVERIUM BROMIDE : 100 MG |
| Manufacturer | BGP PHARMA ULC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A03AX04 PINAVERIUM |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Mar-2016 |
| Original market date | 1998-08-24 00:00:00 |
How is it administered?
Usual adult dosage: 50 mg TID (150 mg/day). Max: 100 mg TID (300 mg/day). Take with a glass of water during meals/snacks. Do not swallow while lying down or just before bedtime.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature (15°C to 30°C).
How is it supplied?
50 mg: Blister packs, boxes of 100 tablets (4 strips of 25). 100 mg: Blister packs, boxes of 100 tablets (5 strips of 20).
Contraindications
Known hypersensitivity to pinaverium bromide or any of the excipients.
Warnings and precautions
Risk of oesophageal irritation/lesions; swallow whole with water during meals. Not for motility dysfunction due to organic disease. Contains lactose.
What can be used instead?
Other Canadian products sharing ATC code A03AX04 PINAVERIUM. 4 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DICETEL | 50 MG | TABLET | BGP PHARMA ULC | MARKETED | DIN 01950592 |
| PINAVERIUM | 100 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02469685 |
| PINAVERIUM | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02469677 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.